The goal of the Commercialization Center for the RADx Blueprint MedTech Translator Cohort 1 is to provide technical, clinical, and commercialization expertise and resources while seeking to accelerate the development of devices to diagnose and treat disorders of the nervous system. The Commercialization Center is a trans-NIH focused activity that requires professional services support across a range of commercialization domains to NIH translational activities. To support rapid technology development, consultants with specialized domain expertise are needed to assess and mitigate risks at various stages.